Table 1 Baseline characteristics of ST-Elevation Myocardial Infarction Patients According to Left Ventricular Ejection Fraction (LVEF)
Variable | LVEF categories | ||||
|---|---|---|---|---|---|
Normal (n = 35) | Mildly reduced (n = 48) | Moderately reduced (n = 94) | Severely reduced (n = 23) | P value | |
Age (year) | 57 (14) | 61 (12) | 63 (12) | 62 (10) | 0.062 |
Number (%) of men | 27 (77.1%) | 36 (75.0%) | 68 (72.3%) | 15 (65.2%) | 0.770 |
Past medical history | |||||
Coronary artery disease | 10 (28.6%) | 18 (37.5%) | 37 (39.4%) | 11 (47.8%) | 0.504 |
Hypertension | 19 (54.3%) | 20 (41.7%) | 48 (51.1%) | 15 (65.2%) | 0.298 |
Diabetes mellitus | 8 (22.9%) | 13 (27.1%) | 31 (33.0%) | 10 (43.5%) | 0.351 |
Smoking | 14 (40.0%) | 22 (45.8%) | 42 (44.7%) | 6 (26.1%) | 0.589 |
Medication on admission | |||||
Statins | 30 (85.7%) | 39 (81.3%) | 63 (67.0%) | 16 (69.6%) | 0.093 |
Aspirin | 11 (31.4%) | 23 (47.9%) | 48 (51.1%) | 14 (60.9%) | 0.125 |
ARBs | 14 (40.0%) | 13 (27.1%) | 34 (36.2%) | 10 (43.5%) | 0.484 |
ACE inhibitors | 5 (14.3%) | 4 (8.3%) | 11 (11.7%) | 3 (13.0%) | 0.850 |
CCBs | 5 (14.3%) | 5 (10.4%) | 14 (14.9%) | 3 (13.0%) | 0.903 |
Beta blockers | 4 (11.4%) | 3 (6.3%) | 5 (5.3%) | 1 (4.3%) | 0.616 |
Thiazide diuretics | 1 (2.9%) | 3 (6.3%) | 5 (5.3%) | 1 (4.3%) | 0.911 |
Anticoagulants | 1 (2.9%) | 1 (2.1%) | 6 (6.4%) | 2 (8.7%) | 0.525 |
Metformin and/or Sulfonylureas | 6 (17.1%) | 10 (20.8%) | 22 (23.4%) | 4 (17.4%) | 0.844 |
Insulin injection | 2 (5.7%) | 3 (6.3%) | 8 (8.5%) | 6 (26.1%) | 0.034 |